December 20, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a medical strategy engagement in pulmonology with a top Canadian biopharmaceutical company.
The company, part of a select group of global leaders in drug development for products treating chronic obstructive pulmonary disorder (COPD), approached Thought Leader Select for support with scientific advisory boards and continuing health education (CHE) initiatives across multiple Canadian provinces. Having already worked with Thought Leader Select to form rosters of key opinion leaders in Canadian rheumatology and oncology circles, the company will formulate its panel of key experts in pulmonology by deploying Thought Leader Select’s team to assess the skills and experiences of physician specialists across the country.
Known for the versatility of applications for its in-house research, Thought Leader Select’s research group will analyze the skills and experience of these leading experts in multiple areas where they collaborate to advance the science of medicine and patient care, including basic and clinical research, scientific journal publishing, treatment guidelines, and more.
Throughout the remainder of the engagement, Thought Leader Select’s consulting team will provide strategic guidance, tactical recommendations for strengthening key opinion leader relationships in the nursing and pharmacy communities, and a suite of tools to promote collaborative work with KOLs. Among these tools are Thought Leader Select’s exclusive Thought Leader Impact maps, which show layers of validated social collaboration among the physicians in areas such as clinical trial work, publishing, and presentations, as well as the company’s exclusive engagement plans, which offer recommendations for working with medical professionals in their preferred areas of achievement. Though Leader Impact maps focus on building KOL teams for collaboration, while the engagement plans focus on working with medical experts at the individual level.
“We’re honored to have another opportunity to help this company shape its outreach and collaboration strategies to promote better treatment alternatives for COPD,” stated Neil Mellor, Thought Leader Select’s global business development consultant. “Working in COPD with this partner company enables us to view our own work as high-impact, as we highlight the great efforts in the Canadian medical community to advance treatment of a disorder that affects millions of people in Canada and around the world.”
About Thought Leader Select
Thought Leader Select is a Chapel Hill, NC-based private consulting firm serving the biopharmaceutical, medical device, and diagnostics industries with strategies, in-house research, and a suite of engagement tools and support for collaborating with and reaching out to key opinion leaders and centers of excellence in medicine.
Thought Leader Select has supported companies as they develop effective treatments to promote better patient and public health across more than 18 therapeutic areas and 50 diseases and conditions. Thought Leader Select’s customized work strengthens medical marketing initiatives, medical affairs outreach, and payer marketing strategies to support market access, pricing, and reimbursement issues.
Media Contact:
Brian Castle, Director of Global Marketing and Client Relations
Phone: 919-360-9690
E-mail: bcastle@thoughtleaderselect.com
